Results 111 to 120 of about 10,434 (181)

In vitro fertilization results of GNRH antagonists and medroxyprogesterone acetate used to prevent premature LH surge during ovarian hyperstimulation. [PDF]

Sci Rep
Dinç C, Arıkan SB, Özer M, Olgan Ş.
europepmc   +1 more source

Topical Medroxyprogesterone Acetate and Corneal Epithelium Healing after Photorefractive Keratectomy: A Randomized, Double-masked Contralateral Eye Study. [PDF]

J Res Pharm Pract
Peyman A, Pourazizi M, Irajpour M, Noorshargh P, Aslani A.   +4 more
europepmc   +1 more source

Effect of medroxyprogesterone acetate dose in progestin-primed ovarian stimulation on pregnancy outcomes in poor ovarian response patients with different body mass index levels. [PDF]

Front Endocrinol (Lausanne)
Zhang Q, He S, Meng Y, Yin T, Ming L, Yang J, Li S.   +6 more
europepmc   +1 more source

The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial. [PDF]

PLoS One
Avenant C, Singata-Madliki M, Bick AJ, Africander D, Balakrishna Y, Storbeck KH, Moliki JM, Dlamini S, Skosana S, Smit J, Beksinska M, Beesham I, Seocharan I, Batting J, Hofmeyr GJ, Hapgood JP.   +15 more
europepmc   +1 more source

Sexual behaviour among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Data from the ECHO randomized trial. [PDF]

PLoS One
Hofmeyr GJ, Singata-Madliki M, Batting J, Steyn P, Thomas KK, Issema R, Beesham I, Mbatsane E, Morrison C, Deese J, Smit J, Philip N, Palanee-Phillips T, Reddy K, Onono M, Mastro TD, Baeten JM, Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium.   +17 more
europepmc   +1 more source

Medroxyprogesterone acetate for uterine shrinkage.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1979
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Anaphylaxis From Medroxyprogesterone Acetate

Obstetrics & Gynecology, 2004
More than 30 million women in more than 90 countries use depot medroxyprogesterone acetate as an injectable contraceptive agent, and it is thought to be very safe. However, it should be recognized that serious and potentially life-threatening adverse effects can occur.A 40-year-old para 2 went into anaphylactic shock after receiving 150 mg of depot ...
Daniel O, Selo-Ojeme, Amna, Tillisi, Christopher C, Welch   +2 more
openaire   +2 more sources

IMMUNOSUPPRESSION WITH MEDROXYPROGESTERONE ACETATE

Transplantation, 1968
The immunosuppressive effects of MPA (medroxyprogesterone acetate) were tested in clinical studies with laboratory dogs and rabbits. The laboratory procedures employed in the studies are explained and results are tabulated and graphed. 2 microscopic photographs illustrate the observed effects.
J G, Turcotte, R F, Haines, G L, Brody, T J, Meyer, S A, Schwartz   +4 more
openaire   +2 more sources